Literature DB >> 19293200

Matrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency.

Christopher J McAloon1, Alice M Wood, Stephen C Gough, Robert A Stockley.   

Abstract

UNLABELLED: Alpha-1-antitrypsin deficiency [AATD] is associated with variable development of emphysema and other features of chronic obstructive pulmonary disease [COPD]. Matrix metalloproteinases [MMPs] are believed to be important in the pathophysiology of COPD, and may therefore confer susceptibility to this phenotype in patients with AATD.
OBJECTIVES: to assess the role of polymorphism of MMP1, MMP3 and MMP12 in AATD phenotypes.
METHODS: 424 PiZZ subjects from the UK AATD Registry were assessed for history of chronic bronchitis [CB], post-bronchodilator lung function impairment and decline of lung function. Tag single nucleotide polymorphisms (SNPs) for MMP1, MMP3 and MMP12 were chosen using HapMap [r(2)>0.8, MAF>0.05] and were genotyped using TaqMan genotyping technologies. Quantitative genetic association was assessed using regression modelling to correct for covariates.
RESULTS: in patients with AATD, carriers of the G allele of rs678815 [MMP3] had lower gas transfer [KCO] [P = 0.025, B =-7.766] than the homozygous wild type, while carriers of the T allele of rs470358 [MMP1] had higher KCO [P = 0.025, B = 6.130].
CONCLUSIONS: variations in MMP1 and MMP3 are associated with gas transfer in AATD, supporting a previous family study showing linkage of KCO to this gene region. Replication of these preliminary data is now required particularly if MMP inhibitors are to be considered as a therapeutic option.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293200     DOI: 10.1177/1753465809102263

Source DB:  PubMed          Journal:  Ther Adv Respir Dis        ISSN: 1753-4658            Impact factor:   4.031


  6 in total

Review 1.  Fibrotic response of tissue remodeling in COPD.

Authors:  Lina María Salazar; Ana Milena Herrera
Journal:  Lung       Date:  2011-02-02       Impact factor: 2.584

2.  Serum Proteins Associated with Emphysema Progression in Severe Alpha-1 Antitrypsin Deficiency.

Authors:  Tatsiana Beiko; Michael G Janech; Alexander V Alekseyenko; Carl Atkinson; Harvey O Coxson; Jeremy L Barth; Sarah E Stephenson; Carole L Wilson; Lynn M Schnapp; Alan Barker; Mark Brantly; Robert A Sandhaus; Edwin K Silverman; James K Stoller; Bruce Trapnell; Strange Charlie
Journal:  Chronic Obstr Pulm Dis       Date:  2017-07-15

3.  Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort.

Authors:  Surya P Bhatt; Hrudaya P Nath; Young-Il Kim; Rekha Ramachandran; Jubal R Watts; Nina L J Terry; Sushil Sonavane; Swati P Deshmane; Prescott G Woodruff; Elizabeth C Oelsner; Sandeep Bodduluri; MeiLan K Han; Wassim W Labaki; J Michael Wells; Fernando J Martinez; R Graham Barr; Mark T Dransfield
Journal:  Respir Res       Date:  2018-12-18

4.  Assessing Patients with Alpha-1 Antitrypsin Deficiency for Corneal Refractive Surgery: A Review and Clinical Experience.

Authors:  Majid Moshirfar; Neil Kelkar; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  J Clin Med       Date:  2022-07-19       Impact factor: 4.964

5.  Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population.

Authors:  Imran Haq; Sally Chappell; Simon R Johnson; Juzer Lotya; Leslie Daly; Kevin Morgan; Tamar Guetta-Baranes; Josep Roca; Roberto Rabinovich; Ann B Millar; Seamas C Donnelly; Vera Keatings; William MacNee; Jan Stolk; Pieter S Hiemstra; Massimo Miniati; Simonetta Monti; Clare M O'Connor; Noor Kalsheker
Journal:  BMC Med Genet       Date:  2010-01-15       Impact factor: 2.103

6.  Alpha-1-antitrypsin deficiency (carrier) as possible risk factor for development of colonic diverticula. A multicentre prospective case-control study: the ALADDIN study.

Authors:  S J Rottier; L C Dreuning; J van Pelt; A A W van Geloven; X D Y Beele; P M Huisman; W Y Deurholt; C A Rottier; K van Leeuwen; M de Boer; G van Mierlo; M A Boermeester; W H Schreurs
Journal:  Colorectal Dis       Date:  2020-09-01       Impact factor: 3.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.